Skip to main content
. Author manuscript; available in PMC: 2024 Jan 5.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 Jul 5;32(7):976–985. doi: 10.1158/1055-9965.EPI-23-0102

Table 5.

Adjusted geometric mean hormone levels by lifetime ovulatory years quartile among postmenopausal women not using hormone therapy at the time of blood draw in the Nurses’ Health Study (n=1976)

Hormone N Ovulatory years Difference per 5 years*

<29.8 Mean (95% CI)* 29.8–33.0 Mean (95% CI)* 33.1–35.9 Mean (95% CI)* ≥36.0 Mean (95% CI)* % (95% CI) p-trend
All women
 Estradiol (pg/mL) 1624 5.1 (4.8, 5.3) 5.1 (4.9, 5.3) 5.3 (5.0, 5.6) 5.4 (5.1, 5.6) 2.7 (0.1, 5.4) 0.05
 Estrone (pg/mL) 1536 21.8 (20.8, 22.8) 22.8 (21.8, 23.8) 23.1 (22.1, 24.2) 23.6 (22.5, 24.7) 2.6 (0.1, 5.1) 0.04
 Estrone sulfate (pg/mL) 1182 232.4 (215.5, 250.7) 233.1 (216.7, 250.8) 223.8 (207.2, 241.7) 237.7 (220.1, 256.7) 0.3 (−3.6, 4.3) 0.89
 Testosterone (ng/dL) 1869 18.0 (17.1, 18.9) 19.5 (18.7, 20.5) 20.9 (20.0, 22.0) 21.0 (20.0, 22.1) 6.2 (3.5, 9.0) <0.0001
 DHEAS (ug/dL) 1374 55.9 (51.5, 60.5) 57.6 (53.5, 62.1) 56.7 (52.4, 61.3) 60.4 (55.8, 65.5) 2.2 (−2.1, 6.7) 0.32
 Prolactin (ng/mL) 1192 8.3 (7.9, 8.7) 9.1 (8.7, 9.6) 9.1 (8.6, 9.6) 9.3 (8.8, 9.8) 1.3 (−1.5, 4.2) 0.35
 SHBG (nmol/L) 1779 55.5 (53.1, 58.1) 56.6 (54.2, 58.9) 57.6 (55.1, 60.1) 54.9 (52.5, 57.3) 0.7 (−1.7, 3.1) 0.57
BMI<25
 Estradiol (pg/mL) 830 4.2 (3.9, 4.5) 4.2 (3.9, 4.5) 4.0 (3.8, 4.3) 4.2 (3.9, 4.5) 0.1 (−3.6, 3.9) 0.96
 Estrone (pg/mL) 789 20.1 (18.9, 21.4) 20.5 (19.4, 21.7) 19.4 (18.2, 20.7) 20.2 (18.9, 21.5) −0.9 (−4.2, 2.5) 0.60
 Estrone sulfate (pg/mL) 591 202.7 (183.3, 224.2) 196.2 (178.5, 215.7) 177.5 (159.9, 197.1) 181.4 (163.1, 201.8) −4.5 (−9.5, 0.8) 0.09
 Testosterone (ng/dL) 958 18.3 (17.1, 19.6) 19.6 (18.5, 20.9) 20.7 (19.3, 22.2) 21.2 (19.7, 22.8) 5.2 (1.3, 9.1) 0.008
 DHEAS (ug/dL) 708 57.1 (51.2, 63.6) 60.0 (54.2, 66.4) 53.1 (47.5, 59.4) 63.9 (56.7, 72.0) 2.5 (−3.7, 9.0) 0.44
 Prolactin (ng/mL) 612 8.5 (7.9, 9.1) 8.7 (8.1, 9.3) 9.4 (8.8, 10.1) 9.5 (8.8, 10.3) 1.5 (−2.2, 5.4) 0.43
 SHBG (nmol/L) 923 67.5 (63.9, 71.3) 68.4 (64.9, 72.0) 72.5 (68.5, 76.8) 67.7 (63.8, 71.8) 0.7 (−2.3, 3.8) 0.64
BMI≥25
 Estradiol (pg/mL) 794 6.1 (5.6, 6.6) 6.2 (5.7, 6.7) 6.9 (6.4, 7.5) 7.2 (6.7, 7.8) 7.3 (3.1, 11.7) 0.0006
 Estrone (pg/mL) 747 23.6 (21.8, 25.4) 24.9 (23.2, 26.7) 27.5 (25.7, 29.4) 28.2 (26.3, 30.2) 7.0 (3.1, 11.1) 0.0004
 Estrone sulfate (pg/mL) 591 264.9 (235.1, 298.5) 274.7 (243.9, 309.3) 279.6 (248.0, 315.1) 313.3 (278.9, 352.0) 6.0 (−0.3, 12.7) 0.06
 Testosterone (ng/dL) 911 17.6 (16.4, 18.9) 19.4 (18.2, 20.8) 21.2 (19.9, 22.7) 20.8 (19.5, 22.2) 7.4 (3.6, 11.4) 0.0001
 DHEAS (ug/dL) 666 54.4 (48.3, 61.4) 55.6 (49.8, 62.1) 60.5 (54.2, 67.6) 57.2 (51.4, 63.6) 1.7 (−4.2, 8.0) 0.58
 Prolactin (ng/mL) 580 8.1 (7.4, 8.8) 9.6 (8.9, 10.4) 8.8 (8.1, 9.5) 9.2 (8.5, 9.9) 1.3 (−2.8, 5.6) 0.54
 SHBG (nmol/L) 859 45.5 (42.2, 49.1) 46.1 (43.0, 49.4) 45.7 (42.7, 48.9) 42.9 (40.1, 45.8) −1.0 (−4.6, 2.5) 0.60
*

Adjusted for age at blood draw (continuous), smoking (never, former, current), alcohol (no regular use, ≤10, >10–20, >20–30, >30 grams/day), years since menopause (continuous), hysterectomy, unilateral oophorectomy, and irregular cycles. Models for all women additionally adjusted for BMI.

p-values for heterogeneity comparing difference in hormone levels per 5 ovulatory years among those with BMI<25 to those with BMI≥25, estradiol: p=0.07, estrone: p=0.02, estrone sulfate: p=0.04, testosterone: p=0.47, DHEAS: p=0.94, prolactin: p=0.37, SHBG: p=0.66.